A case of severe visceral leishmaniasis resulting from travel to Greece: Table 1
- 1 September 2009
- journal article
- Published by BMJ
- Vol. 2009
Abstract
Visceral leishmaniasis is rare in the developed world, particularly in immunocompetent hosts. It must be considered, however, in patients who are unwell, febrile and unresponsive to conventional antibiotics with a history of travel to areas where leishmaniasis is endemic. A case of more severe clinical manifestations than have been previously reported in Australia is presented here. The recent introduction of PCR technology for the detection ofLeishmaniain Australia has improved the diagnosis and management of leishmaniasis. Treatment with liposomal amphotericin B proved to be very effective in this severe case of visceral leishmaniasis.Keywords
This publication has 11 references indexed in Scilit:
- An Australian case of New World cutaneous leishmaniasisMedical Journal of Australia, 2007
- Chronic Granulomatous Disease; fundamental stages in our understanding of CGDMedical Immunology, 2006
- New world cutaneous leishmaniasis in travellersThe Lancet Infectious Diseases, 2006
- Advances in leishmaniasisThe Lancet, 2005
- Visceral leishmaniasis: a trip to the Greek Islands is not always idyllicMedical Journal of Australia, 2004
- Progress in the treatment of a neglected infectious disease: visceral leishmaniasisExpert Review of Anti-infective Therapy, 2004
- Mutational analysis of patients with p47-phox–deficient chronic granulomatous diseaseExperimental Hematology, 2001
- Visceral Leishmaniasis and Other Severe Infections in an Adult Patient with p47- phox -Deficient Chronic Granulomatous DiseaseInfection, 2000
- LeishmaniasisThe Lancet, 1999
- Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.Journal of Clinical Investigation, 1983